Latest posts 5
Dr. Kaylee Byers shares the big takeaway from this episode of Nice Genes and why things could be changing for people with pancreatic cancer. 🧬
For years, KRAS has been considered undruggable but new developments in targeted treatments are opening up possibilities.
🎧link.cohostpodcasting.com/b87cc2cc-6ed3-…
For years, KRAS has been considered undruggable but new developments in targeted treatments are opening up possibilities.
🎧link.cohostpodcasting.com/b87cc2cc-6ed3-…
0:31
Pancreatic cancer has long been difficult to treat, but could KRAS finally be its match? 🧬
In this episode we explore a promising new class of drugs and what it could mean for the future of pancreatic cancer care.
🎧 Listen now: link.cohostpodcasting.com/b87cc2cc-6ed3-…
In this episode we explore a promising new class of drugs and what it could mean for the future of pancreatic cancer care.
🎧 Listen now: link.cohostpodcasting.com/b87cc2cc-6ed3-…
0:46
A mammoth-sized thank you to everyone who joined us for #DRDK2026! 🦣
Dr. Beth Shapiro sparked a fascinating evening of questions about ancient DNA, de-extinction and whether we could really bring back the mammoth.
Thanks to Beth and everyone who made it such a memorable event!
Dr. Beth Shapiro sparked a fascinating evening of questions about ancient DNA, de-extinction and whether we could really bring back the mammoth.
Thanks to Beth and everyone who made it such a memorable event!
Welcome Dr. Roshini Moodley Naidoo our new President + CEO
Roshini brings global health care leadership, business expertise + a collaborative approach to advancing innovation. Thanks to Dr. Tony Brooks for his leadership as Interim President + CEO over the past 13 months.
genomebc.ca/staff/roshini-…
Roshini brings global health care leadership, business expertise + a collaborative approach to advancing innovation. Thanks to Dr. Tony Brooks for his leadership as Interim President + CEO over the past 13 months.
genomebc.ca/staff/roshini-…